Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Riordan

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Cells|October 15, 2024
The Structures, Functions, and Roles of Class III HDACs (Sirtuins) in Neuropsychiatric DiseasesRobin E Bonomi, William Riordan, Juri G Gelovani
Radiology|April 1, 2009
Breast-specific gamma imaging for detection of breast cancerWilliam Riordan, Rachel F Brem, Angelique C Floerke, et al.
Biotechnology and Bioengineering|April 17, 2009
Design of salt-tolerant membrane adsorbers for viral clearanceWilliam Riordan, Steve Heilmann, Kurt Brorson, et al.
The Journal of Trauma|January 11, 2011
Triaging to a regional acute care surgery center: distance is criticalJose J Diaz, Patrick Norris, Oliver Gunter, et al.
The Journal of Urology|November 21, 2002
Colonic adenocarcinoma in a congenital rectourethral fistula in association with high imperforate anus and multiple genitourinary anomaliesTravis Clark, William Riordan, Ana M Grau, et al.
Thrombosis and Haemostasis|March 18, 2006
Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activatorLi Zhang, Zheng Gang Zhang, Xianshuang Liu, et al.
The Journal of Trauma|September 12, 2008
Cardiac uncoupling and heart rate variability are associated with intracranial hypertension and mortality: a study of 145 trauma patients with continuous monitoringNathan Teague Mowery, Patrick R Norris, William Riordan, et al.
Gynecologic Oncology|August 29, 2009
A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group studyCarol Aghajanian, John A Blessing, Kathleen M Darcy, et al.
Clinical Therapeutics|January 30, 2010
Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: a prospective, multicenter, open-label, randomized, two-way crossover drug-drug interaction studyKarthik Venkatakrishnan, Michael Rader, Ramesh K Ramanathan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2004
Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomibKai Sun, Lisbeth A Welniak, Angela Panoskaltsis-Mortari, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Cells|October 15, 2024
The Structures, Functions, and Roles of Class III HDACs (Sirtuins) in Neuropsychiatric DiseasesRobin E Bonomi, William Riordan, Juri G Gelovani
Radiology|April 1, 2009
Breast-specific gamma imaging for detection of breast cancerWilliam Riordan, Rachel F Brem, Angelique C Floerke, et al.
Biotechnology and Bioengineering|April 17, 2009
Design of salt-tolerant membrane adsorbers for viral clearanceWilliam Riordan, Steve Heilmann, Kurt Brorson, et al.
The Journal of Trauma|January 11, 2011
Triaging to a regional acute care surgery center: distance is criticalJose J Diaz, Patrick Norris, Oliver Gunter, et al.
The Journal of Urology|November 21, 2002
Colonic adenocarcinoma in a congenital rectourethral fistula in association with high imperforate anus and multiple genitourinary anomaliesTravis Clark, William Riordan, Ana M Grau, et al.
Thrombosis and Haemostasis|March 18, 2006
Treatment of embolic stroke in rats with bortezomib and recombinant human tissue plasminogen activatorLi Zhang, Zheng Gang Zhang, Xianshuang Liu, et al.
The Journal of Trauma|September 12, 2008
Cardiac uncoupling and heart rate variability are associated with intracranial hypertension and mortality: a study of 145 trauma patients with continuous monitoringNathan Teague Mowery, Patrick R Norris, William Riordan, et al.
Gynecologic Oncology|August 29, 2009
A phase II evaluation of bortezomib in the treatment of recurrent platinum-sensitive ovarian or primary peritoneal cancer: a Gynecologic Oncology Group studyCarol Aghajanian, John A Blessing, Kathleen M Darcy, et al.
Clinical Therapeutics|January 30, 2010
Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: a prospective, multicenter, open-label, randomized, two-way crossover drug-drug interaction studyKarthik Venkatakrishnan, Michael Rader, Ramesh K Ramanathan, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 19, 2004
Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomibKai Sun, Lisbeth A Welniak, Angela Panoskaltsis-Mortari, et al.
Pageof 2